Health knowledge made personal
› Share page:

Posts

Sort by: Most recent | Name
Histiocytic sarco ... by Mark Levin Posted in: Blog Posts in Cancer Histiocytic sarcoma (HS) is a rare neoplasm of uncertain etiology. Most recently, the diagnostic criteria for this entity have been revised with inclusion of di ... Read on »
The issue in is whether t ... by Mark Levin Posted in: Blog Posts in Cancer The issue in is whether the docetaxel/ cyclophashamide regimen has a febrile neutropenia rate of 20% or more when used in the usual manner in adjuvant treatmetn of brea ... Read on »
Xeliri is supported by cu ... by Mark Levin Posted in: Blog Posts in Cancer Xeliri is supported by current medical literature for first or second line treatment of metastatic colon cancer. There are several pahse II studies that indicate effect ... Read on »
Abraxane and gemcitabine for pancreatic cancer by Mark Levin Posted in: Blog Posts in Cancer Abraxane (nab-paclitaxel) is an albumin-bound, 130-nm particle form of paclitaxel that was developed to avoid cremophor/ethanol-associated toxicities associated with th ... Read on »
Abraxane and gemcitbine for pancreatic cancer by Mark Levin Posted in: Blog Posts in Cancer Abraxane and paclitaxel may be very effective for metastatic pancreatic cancer but no full scale studies have yet been published in peer-reviewed venues. Abraxane ... Read on »
Abraxane caroplatin for non-small cell lung cancer by Mark Levin Posted in: Blog Posts in Cancer Abraxane (nab-paclitaxel) is an albumin-bound, 130-nm particle form of paclitaxel that was developed to avoid cremophor/ethanol-associated toxicities associated with th ... Read on »
Accelerated Partial Breast Radiotherapy by Mark Levin Posted in: Blog Posts in Cancer There are several methods for delivering partial breast irradiation. Among them is Strut Assisted Volume Implant (SAVITM): this device has 7-11 "struts" or catheters th ... Read on »
Acute bleeding in patients who refuse transfusion: Role of erythropoietin by Mark Levin Posted in: Blog Posts in Cancer Acute bleeding in patietns who refuse transfusion is a difficult clincial challenge. There is some avidence that recovery is enchanced by adminsitering erytropoietin bu ... Read on »
Acyclovir prophylaxis for Velcade based therapies by Mark Levin Posted in: Blog Posts in Cancer The bortezomib and dexamethasone treatment is myelosupressive. The APEX trial demonstrated an incidence of H. Zoster of 13% in the bortezomib-treated arm compared with ... Read on »
Adjuvant Abraxane by Mark Levin Posted in: Blog Posts in Cancer Since 1998, the standard of adjuvant care for patients with node-positive breast cancer in the United States and other parts of the world has been treatment with doxorubic ... Read on »
Adjuvant and neoadjuvant chemotherapy for bladder cancer by Mark Levin Posted in: Blog Posts in Cancer The role of perioperative  chemotherapy for bladder cancer is not clear. The remains doubt about effectiveness of such chemotherapy and whether is should be given preop ... Read on »
Adjuvant Avastin for breast cancer by Mark Levin Posted in: Blog Posts in Cancer There is a great deal of interest in the adjuvant use of Avastin for breast cancer. FDA approved Avastin on 2/27/08 for first line treatment of metastatic cancer only. It ... Read on »
Adjuvant chemotherapy after Whipple's for chalngiocarcinoma. by Mark Levin Posted in: Blog Posts in Cancer   The role of adjuvant chemothhapy after complete resection of cholangiocarcinoma is changing. The cancer have a high incidence of local failure after surgical re ... Read on »
Adjuvant chemotherapy for oseosarcoma by Mark Levin Posted in: Blog Posts in Cancer Despite an optimal loco-regional treatment, 35%–50% of patients with sarcoma will develop metastasis. Systemic chemotherapy is then the standard treatment; the ... Read on »
Adjuvant therapy of rectal cancer, including stage II by Mark Levin Posted in: Blog Posts in Cancer Adjuvant chemotherapy for Stage II colon cancer is controversial but the field is now returning back to it and guideliens stae taht it si optional but accepted. There is g ... Read on »
Admission for coronary syndrome by Mark Levin Posted in: Blog Posts in Cancer Millman considers a one day admission appropriate for acute coronary syndrome. This is an umbrella term used to cover any group of clinical symptoms compatible with acute ... Read on »
Adrenal cancer after resection: followup imaging by Mark Levin Posted in: Blog Posts in Cancer Adrenal cancer is not common and the clincial experience with it is limited. There is much information on how to follow it before resection but not as much on how to fo ... Read on »
Afinitor and Nexavar by Mark Levin Posted in: Blog Posts in Cancer Everolimus has been approved by the US Food and Drug Administration (FDA) as the first oral, daily therapy (5 mg and 10 mg tablets) to treat advanced kidney cancer afte ... Read on »
Afinitor for breast cancer by Mark Levin Posted in: Blog Posts in Cancer Early clinical trials suggested that shows that the addition of Afinitor to chemotherapy with Herceptin can overcome resistance to Herceptin. Preclinical data have shown ... Read on »
Afinitor for carcinoid by Mark Levin Posted in: Blog Posts in Cancer Everolimus has been approved by the US Food and Drug Administration (FDA) as the first oral, daily therapy (5 mg and 10 mg tablets) to treat advanced kidney cancer after f ... Read on »